Clinical Roundup Free educational workshop on conducting sexual and gender minority cancer research available to early career professionals September 09, 2022Vol.48 No.32
Clinical RoundupFree Subcutaneous formulation of Tecentriq demonstrates positive phase III results August 05, 2022Vol.48 No.31
Clinical RoundupFree Thermo Fisher introduces assays for MRD detection in myeloid malignancies August 05, 2022Vol.48 No.31
Clinical Roundup ASCO, ACCC publish resources for improving diversity in clinical trials July 29, 2022Vol.48 No.30
Clinical Roundup JNCCN paper: Chemo drugs from “rogue” online pharmacies could endanger leukemia patients July 29, 2022Vol.48 No.30
Clinical Roundup Study: Adults with limited English proficiency have worse access to health care and cancer prevention services July 29, 2022Vol.48 No.30
Clinical Roundup AVIL gene responsible for glioblastoma also causes rhabdomyosarcoma, UVA researchers find July 29, 2022Vol.48 No.30
Clinical Roundup Study demonstrates gender disparity in speakers at board review lectures July 29, 2022Vol.48 No.30
Clinical Roundup Yale Cancer Center study: For Medicaid-covered patients with cancer, insurance does not always mean access July 22, 2022Vol.48 No.29
Clinical Roundup Merck to stop phase III LYNK-003 trial evaluating Lynparza with or without bevacizumab in metastatic colorectal cancer July 22, 2022Vol.48 No.29
